Find Academic Supervisors

Lukas MillesView profile

Professor

• Protein Design
• Biophysics
• Deep Learning
• +3 more

Prof. Dr. Lukas Milles is a Professor (W2) at the Gene Center, Ludwig-Maximilians-Universität (LMU) Munich and an Emmy Noether Group Leader at the Max Planck Institute (MPI) of Biochemistry in Martinsried. His research focuses on de novo protein design, leveraging deep learning and biophysical characterization to engineer proteins with novel functions. He holds appointments at both LMU and the MPI, bridging computational and experimental approaches in biomolecular design. Academically, Milles earned a PhD in Physics/Biophysics from LMU (2014–2018) under Prof. Hermann Gaub, followed by postdoctoral training at the University of Washington’s Institute for Protein Design (2019–2023) with Prof. David Baker. His interdisciplinary work spans protein stability, host-pathogen interactions, and synthetic biology, with a focus on autocatalytic enzymes and catch-bond mechanisms inspired by bacterial pathogens. Key research interests include single-molecule biophysics, high-throughput protein screening, and machine learning-driven design. His lab develops tools like RFdiffusion and ProteinMPNN to predict and engineer protein structures and functions. Notable achievements include designing mechanically robust proteins and elucidating the molecular basis of pathogen adhesin stability. Scientific awards include the HFSP Cross-Disciplinary Fellowship (2020–2023) and EMBO Long-Term Fellowship (2019–2020). His group actively collaborates with institutions worldwide, advancing applications in biomedicine and biomaterials. Current projects prioritize synthetic protein systems for targeted therapies and mechanoresponsive biomolecules.

• Beta Cell Therapy
• Signal Transduction Mechanisms
• Biomaterials Engineering
• +3 more

Karine Hellemans is a Professor of Clinical Sciences at Brussels Free University-VUB since 2006, coordinating the Diabetes Research Center and the Center for Beta Cell Therapy in Diabetes. Her research focuses on beta cell biology, biomaterials, and preclinical methods to enhance beta cell function. She holds a PhD in Medical Sciences (2003) and an MSc in Biology (1991). Affiliations: Brussels Free University-VUB, Diabetes Research Center, Center for Beta Cell Therapy Research interests include signal transduction pathways in beta cells, biomaterial development for cell therapy, and improving functional beta cell mass. Recent work emphasizes microfluidic techniques for drug delivery and beta cell implant optimization. Key Projects: Core Facility Animalarium (2018–2025), μFlow Cell (2024–2028), and HERC67 (2024–2028). Awards: 2007 Poster Prize from the Belgian Society for Cell Biology. Labs/Teams: Head of the Beta Cell Therapy Coordination Unit, involved in multidisciplinary collaborations on beta cell therapy and biomaterials.

Willem StaelsView profile

Researcher

• Pancreatic Biology
• Type 1 Diabetes
• Beta Cell Regeneration
• +3 more

Willem Staels is an Unpaid employee at the Vrije Universiteit Brussel (VUB), affiliated with the Faculty of Medicine and Pharmacy and the Department of Genetics, Reproduction and Development. He holds a MD and PhD and maintains a clinical role as a UZB Physician in Pediatrics. His research focuses on pancreatic beta cell biology, diabetes mechanisms, iron metabolism, and pediatric obesity. Staels leads multiple interdisciplinary projects, including investigations into beta cell regeneration and vascular signaling in diabetes therapy. Education: MD and PhD (specific institutions not detailed in text, inferred from titles). Research Interests: Staels' work spans diabetes pathophysiology, particularly beta cell dysfunction and regeneration. He explores iron's role in beta cell maturation and investigates pediatric obesity's metabolic and inflammatory consequences. Recent projects include studies on beta cell iron metabolism and vascular signals for maturation of stem cell-derived beta cells. Awards: Recognized with the Young Investigator Award (ESPE 2021), Horlait Dapsens Prize (2018), and SANDOZ BELSPEED ESPE Award (2024). His research has been featured in high-impact journals like Trends in Endocrinology and Metabolism and Diabetes Care . Grants & Projects: Leads 11 active projects, including the FWOAL1158 (neurogenin3 in beta cell regeneration) and HERC66 (3D cellular imaging). Collaborates widely with institutions like the University of Leuven and VIB. Labs/Teams: Works within the Genetics Reproduction and Development group at VUB, contributing to multi-institutional initiatives like the 3D-CELLMAP imaging project.

• Type 1 Diabetes
• Endocrinology
• Clinical Chemistry
• +5 more

Annelien Van Dalem serves as a Clinical Professor in the Department of Clinical Biology within the Faculty of Medicine and Pharmacy at Vrije Universiteit Brussel. Her clinical practice is based at University Hospital Brussels (UZB) where she maintains dual expertise in Pharmaceutical and Pharmacological Sciences alongside Clinical Biology. With an ORCID identifier (0000-0003-2304-5298) and active research profile through 2025, she represents a key figure in diabetes research and clinical laboratory medicine at this Belgian academic institution. Dr. Van Dalem's research program centers on Type 1 Diabetes Mellitus with 100% research footprint concentration according to institutional metrics. Her work specifically investigates autoantibodies (64% research footprint), C-Peptide dynamics (64%), and therapeutic responses to agents like otelixizumab (49%). Additional expertise includes Zinc Transporter 8 (30%), Ion-Selective Electrode technology (24%), and Glucose monitoring systems (22%). Her laboratory focuses on early biological markers for diabetes prediction, complications assessment, and contribution to prevention trial design through epidemiological approaches. Analysis of her publication record reveals a clear research trajectory spanning clinical chemistry methodology and diabetes pathophysiology. Recent work demonstrates increasing focus on continuous glucose monitoring technologies and therapeutic response prediction, while maintaining strong contributions to analytical interference issues in laboratory medicine. Her collaborative network includes major diabetes research groups across Belgium with significant work on otelixizumab trials and beta cell function preservation. Scientific recognition includes: Award 'Bank J. Van Breda & C°' (2011) Dr. Van Dalem actively supervises graduate research, most recently co-advising Janssens, A.'s 2024 Master's thesis on maglumi X3 platform validation for multiple analytes. Her institutional activities show extensive participation in professional development through 66 recorded events (2017-2025), including 32 conference participations and 29 workshop engagements. Current activities focus on AI applications in clinical biology, viral hepatitis diagnostics, HLA typing, and multiple myeloma diagnostics. Her laboratory maintains dual research streams: one focused on diabetes biomarker discovery and validation, and another addressing analytical challenges in clinical chemistry including biotin interference and ion-selective electrode measurement accuracy. Recent collaborative work extends into cardiovascular outcomes research as evidenced by the 2025 FFRCT registry analysis.

Konrad PeukertView profile

Physician Scientist

• Immunology
• Critical Care Medicine
• Acute Respiratory Distress Syndrome (ARDS)
• +3 more

Dr. med. Konrad Peukert is a physician-scientist at the University of Bonn’s Medical Faculty, affiliated with the Department of Anesthesiology and Intensive Care Medicine . He specializes in critical care medicine, focusing on immunological and metabolic mechanisms in critically ill patients, particularly acute respiratory distress syndrome (ARDS). His work bridges clinical practice and research, addressing personalized therapies through ARDS subphenotyping. Education: Medical degree from Hannover Medical School. Joined University Hospital Bonn in 2015 for clinical and postdoctoral training. Research Interests: Peukert’s research targets metabolic and immunological pathways in ARDS. Key projects include identifying ARDS subtypes, exploring beta-hydroxybutyrate’s role in T cell functionality (Nature, 2022), and cytokine inhibition strategies (Am J Respir Crit Care Med, 2021). Current work investigates ARDS-related pulmonary fibrosis with the Bonn-Hannover-Zurich Study Group. Awards: Fresenius Foundation Research Grant (DGAI), Research Award for Experimental Medicine (DIV). Collaborations: Interdisciplinary team at the Bonn Center of Immunology and translational studies with clinical partners.

• Biomedical Imaging
• Cancer Research
• Nanotechnology
• +2 more

Dong Li serves as a Research Fellow in Biomedical Science Histology within the School of Natural Sciences at Middlesex University. His research integrates computational methods with biomedical science to address challenges in cancer diagnostics and treatment, particularly focusing on human papillomavirus (HPV) and cervical cancer. Research Interests: Dr. Li's work spans four primary domains: Biomedical Imaging : Application of deep learning and GANs to detect and visualize HPV in microscopic images. Cancer Modeling : Development of 3D in vitro models for breast and cervical tissues to study cancer progression. Nanomedicine : Design of folate-mediated liposomal systems for targeted arsenic trioxide delivery in cervical cancer therapy. Molecular Oncology : Investigation of hCG beta's role in epithelial-mesenchymal transition and tumor invasion pathways. Publication Trends: Dr. Li's 14 publications (2008-2022) demonstrate an evolution from molecular/cellular studies toward AI-driven diagnostics. Early work (2008-2015) focused on tissue engineering and drug mechanisms, while recent efforts (2020-2022) leverage deep learning for HPV detection, revealing interdisciplinary innovation at the oncology-computer science-nanotechnology intersection. Scientific Awards: None documented. Advising and Grants: No details provided regarding student supervision or research funding. Research Groups: Affiliated with a Histology Research institute, indicating active collaboration within specialized histology and biomedical imaging research teams at Middlesex University.

Homer BousheyView profile

Professor

• Asthma
• Bronchial Hyperreactivity
• Airway Inflammation
• +12 more

Homer Boushey, MD, is a Professor in the Department of Medicine at the University of California, San Francisco (UCSF), School of Medicine. He is a leading researcher in asthma, airway inflammation, and respiratory viral infections, particularly human rhinoviruses. His work integrates clinical research, microbiome science, and novel therapeutic development. Dr. Boushey’s research focuses on bronchial hyperreactivity, airway mucous secretion, vascular permeability, and the role of viral infections in asthma exacerbations. He has pioneered non-invasive methods like sputum induction to assess airway inflammation and has contributed to understanding how airway epithelial injury and repair influence viral susceptibility. His team collaborated on developing microarray-based viral detection and expanding it to identify novel rhinovirus strains. He is deeply involved in studying the interactions between the microbiome (gut, airway, and environmental), immune function, and asthma development, particularly in urban children. His recent publications (2019–2024) highlight ongoing work in the nasal and upper airway microbiome, antiviral therapeutics targeting host proteins, digital asthma management, and early-life interventions with probiotics. His research spans virology, immunology, microbiome science, and clinical trials, reflecting a translational and systems-level approach to asthma and allergic diseases. Dr. Boushey has received continuous funding from NHLBI and NIAID, serving as a Principal Investigator for UCSF’s site in national asthma research networks. He is a co-investigator in studies on oligosaccharides in airway secretions and probiotic supplementation in infants to prevent allergic disease. His collaborations include key figures like Dr. John Fahy, Dr. Susan Lynch, and Dr. Michael Cabana. He has made significant contributions to clinical asthma trials, including studies on inhaled corticosteroids, long-acting beta-agonists, leukotriene antagonists, and tiotropium. He has also investigated biomarkers of asthma control and the impact of beta-agonist genetics on treatment response. Dr. Boushey mentors numerous researchers and has been instrumental in shaping asthma research policy and clinical guidelines. He has contributed to consensus statements from the American Thoracic Society and European Respiratory Society on asthma control and endpoints in clinical trials.

Juan S. BonifacinoView profile

Researcher

• Cell Biology
• Molecular Biology
• Protein Trafficking
• +4 more

Juan S. Bonifacino is a researcher at the National Institutes of Health (NIH), leading the Section on Intracellular Protein Trafficking and serving as Associate Scientific Director of the Neurosciences and Cellular and Structural Division at the NICHD. He holds a Ph.D. in Biochemistry from the University of Buenos Aires, Argentina, and completed postdoctoral training at NIDDK and NICHD. His research focuses on molecular mechanisms of intracellular protein trafficking, including coat proteins, neuronal sorting, organelle positioning, and neurodevelopmental disorders arising from trafficking defects. Key research interests include the study of protein transport pathways, endosomal retrieval systems, and diseases linked to trafficking dysfunction. Bonifacino’s lab has contributed to understanding AP complexes, BLOC-3, BORC, and retromer, with implications for neurodegenerative and genetic disorders. He oversees a lab that shares reagents via Addgene, emphasizing collaborative research. Notable achievements include pioneering studies on lysosome positioning, autophagosome formation, and the role of VPS51 in neurodevelopmental disorders. Collaborations and mentorship in the field of cellular and structural biology further highlight his contributions to advancing biomedical research.

Susan K. LoganView profile

Associate Professor

• Cellular Growth Control
• Androgen Receptor
• Cancer Biology
• +3 more

Susan K. Logan is an Associate Professor in both the Department of Urology and the Department of Biochemistry and Molecular Pharmacology at the NYU Grossman School of Medicine. She holds a PhD from Brandeis University and leads the Logan Lab, focusing on cellular growth control, androgen receptor signaling, cancer biology, and pharmacology. Her research integrates molecular mechanisms in prostate cancer, stem cell biology, and drug development. Notable work includes studying beta-catenin/TCF interaction modulation, androgen receptor transcriptional activity, and LINE-1 retrotransposon regulation using CRISPR-Cas9 and proteomic techniques. Publications highlight translational research in therapy-resistant prostate cancer, peptoid-based therapeutics, and PIM1 kinase substrates. She collaborates widely with institutions like Harvard and Memorial Sloan Kettering Cancer Center. No scientific awards are explicitly listed in her profile, but her work has been featured in high-impact journals like Molecular Cancer Therapeutics and Communications Biology . Her lab's focus on Sertoli cell biology and blood-testis barrier integrity underscores interdisciplinary interests in reproductive and molecular biology. Active grants and funding sources are not detailed here, but her work aligns with NYU Langone's translational medicine priorities.

Jamie I. BaumView profile

Associate Professor

• Nutrition
• Dietary Protein
• Amino Acid Metabolism
• +6 more

Jamie I. Baum is an Associate Professor in the Department of Food Science at the University of Arkansas, where she also serves as Director of the Center for Human Nutrition within the Division of Agriculture. She has been a faculty member since 2011 and holds adjunct affiliation with the School of Human and Environmental Sciences and membership in the Cell and Molecular Biology Program. BS in Dietetics, University of Illinois at Urbana-Champaign (2000) PhD in Nutritional Sciences, University of Illinois at Urbana-Champaign (2004) Postdoctoral Fellow, Cellular & Molecular Physiology, Pennsylvania State University (2006) Dr. Baum's research centers on the role of dietary protein, amino acids, and fatty acids in regulating skeletal muscle function and preventing chronic diseases. Her work spans from molecular mechanisms to human clinical studies, emphasizing metabolic health in aging populations and the impact of nutrition on muscle physiology. She employs a 'molecule-to-man' approach, integrating biochemical, cellular, and physiological data. Her recent publications highlight trends in protein metabolism, insulin and glucagon signaling, mTORC1 regulation, and dietary interventions for metabolic health. Research areas include aging, sarcopenia, obesity, diabetes, and exercise performance, with strong emphasis on translational nutrition science. American Federation for Aging Research Travel Award National Institute on Aging Butler-Williams Scholars Program Outstanding Mentor Award, University of Arkansas (2015, 2014) American Diabetes Association Postdoctoral Mentor-Based Fellow Claude D. Pepper Older Americans Independence Centers Junior Faculty Scholarship Dr. Baum has mentored numerous students and secured research funding focused on nutrition and metabolic health. She teaches undergraduate courses such as Exploring Topics in Food Science and Food for Health , and directs the Food Science Internship Experience . At the graduate level, she teaches Regulation of Metabolism in Human Health and Disease . She has also contributed to outreach programs like Cooking Matters and Shopping Matters, demonstrating commitment to community nutrition education.

Andrew HorvaiView profile

Medical Educator

• Molecular Pathology
• Cancer Research
• Genomic Profiling
• +3 more

Andrew Horvai is a Medical Educator at the University of California San Francisco (UCSF) School of Medicine, Department of Pathology. With dual training in medicine (M.D.) and biomedical sciences (Ph.D.), he specializes in molecular pathology, cancer research, and genomic profiling of complex tumors. Education: B.S. in Biology (1990) from UCLA, M.D./Ph.D. in Biomedical Sciences and Medicine (1998) from UCSD Training: General Surgery residency, Pathology residency (2002), and Surgical Pathology fellowship (2003) at UCSF His research focuses on NF1-associated peripheral nerve sheath tumors, sarcomas, and rare bone/soft tissue neoplasms. Using genomic and spatial transcriptomic profiling, he investigates tumor progression mechanisms, immune microenvironments, and biomarkers for early detection and targeted therapies. Key publication themes include: Molecular characterization of malignant peripheral nerve sheath tumors (2025) Epigenetic distinctions in chondroblastoma (2025) Metabolic dependencies in primary vs. metastatic tumors (2023) Diagnostic challenges in rare tumors like calcifying fibrous tumors and ossifying fibromas Scientific honors include Phi Beta Kappa (1990), Lucille P. Markey Predoctoral Fellowship (1992), Student Surgical Research Award (2011), and Excellence in Teaching from UCSF's Academy of Medical Educators.

Chandra BhattacharyaView profile

Assistant Professor

• Organic Chemistry
• Chemical Biology
• Medicinal Chemistry
• +8 more

Chandra Bhattacharya is an Assistant Professor at the University of Nevada, Las Vegas in the Department of Chemistry and Biochemistry . As founder of the university's mRNA Nanomedicine Program , her research bridges bioengineering , drug delivery , and personalized medicine through carbohydrate-based molecular targeting. Assistant Professor, Medicinal Chemistry (UNLV, 2025) Postdoc, Bioengineering (MIT, 2022–2024) Postdoctoral Researcher (Caltech, 2009) PhD, Organic and Bioorganic Chemistry (Arizona State University) MSc, Chemistry (Indian Institute of Technology Kharagpur) BSc, Chemistry (Presidency College, India) Her research focuses on: Smart Biomaterials for glucose-responsive insulin delivery Glycochemistry to decode carbohydrate-protein interactions mRNA Delivery via lipid nanoparticles Cancer Immunotherapy using CAR T-cell engineering Key article trends include: Organ-specific mRNA delivery systems Carbohydrate-functionalized nanocarriers Viscoelastic material characterization Immune cell targeting via glycolipids Major awards: JDRF Postdoctoral Fellowship (2018–2021) DAAD Research Internship (2008) Mentioned in 2024 PhRMA Foundation grant for CAR T cell innovation Lab team includes 4 graduate students and 1 post-baccalaureate researcher. Current projects focus on in vivo T-cell reprogramming with mRNA-loaded nanoparticles.

• Biochemistry
• Neuroscience
• Physical Chemistry
• +7 more

Vladana Vukojevic is an Associate Professor of Biochemistry and Principal Researcher at Karolinska Institutet's Department of Clinical Neuroscience, where she leads the Experimental Alcohol- and Drug Dependence Research group. She holds a PhD in Physical Chemistry from the University of Belgrade (2000) and earned her Docent title from Karolinska Institutet in 2011. Her research focuses on cellular mechanisms underlying alcohol use disorder, amyloid diseases, and neuropeptide signaling. Her primary research investigates molecular mechanisms of addiction through quantitative fluorescence microscopy techniques. Key areas include: Opioid receptor dynamics in alcohol dependence Amyloid-β aggregation in Alzheimer's disease Hypothalamic-pituitary-adrenal (HPA) axis modeling Development of advanced fluorescence correlation spectroscopy Vukojevic's publications demonstrate consistent focus on neuropharmacology and biophysical methods. Recent work emphasizes: Nanoscale receptor organization in addiction Amyloid plaque detection methods Transcription factor dynamics Computational modeling of stress responses She teaches advanced analytical methods through doctoral courses including Functional Fluorescence Microscopy Imaging in Biomedical Research and contributes to pedagogical development at Karolinska Institutet and Hokkaido University.

• Food Biotechnology
• Genetic Engineering
• Enzyme Technology
• +5 more

Dr. Thu Ha Nguyen is a Senior Lecturer and researcher in Food Biotechnology at the Institute of Food Technology, Department of Biotechnology and Life Sciences, University of Natural Resources and Life Sciences, Vienna (BOKU). She completed her doctorate at BOKU in 2006 and earned her habilitation in Food Biotechnology in 2018, becoming a private lecturer. Her research focuses on the enzymatic synthesis of prebiotics, particularly using bacterial β-galactosidases to produce galacto- and hetero-oligosaccharides from lactose and other substrates. Her research interests include: Food Biotechnology Genetic Engineering Enzyme Technology Prebiotic Synthesis Microbial Biotechnology Carbohydrate Bioengineering Dr. Nguyen's recent publications highlight her work on recombinant enzyme production in Lactobacillus and E. coli, immobilization techniques, and valorization of dairy byproducts like whey. Her studies often involve cloning, expression, and characterization of glycosidases from Bifidobacteria and Lactobacilli, with applications in functional foods and gut health. She has received the Elise Richter Fellowship from the Austrian Science Fund (FWF) in 2016, a prestigious award supporting women in postdoctoral research. Her scientific contributions include numerous conference presentations across Europe, the US, and Asia. Dr. Nguyen has supervised university theses and contributed to knowledge transfer through lectures and outreach. She has not been listed as part-time, retired, or former staff, and remains an active academic at BOKU.

• Computational Biology
• Bioinformatics
• Plant Genomics
• +7 more

Juliane Dohm is an Associate Professor at the Institute of Computational Biology, Department of Biotechnology and Food Science, University of Natural Resources and Life Sciences, Vienna (BOKU). Her research focuses on computational genomics, particularly in plant species such as beet, spinach, and quinoa, using high-throughput sequencing and bioinformatics tools to understand genome evolution, structural variation, and crop domestication. Education: Habilitation in Bioinformatics (Venia Docendi), University of Natural Resources and Life Sciences, Vienna, 2020 Doctorate in Bioinformatics (Dr. rer. nat.), University of Potsdam and Max Planck Institute for Molecular Genetics Berlin, 2008 Diploma in Biochemistry (Dipl.-Biochem.), Ruhr University Bochum and Max Planck Institute for Molecular Physiology Dortmund, 2002 Her research interests span computational biology, plant genomics, structural variation, phylogenetics, population genomics, and machine learning applications in genomic data analysis . She employs long-read sequencing, k-mer analysis, and comparative genomics to unravel evolutionary relationships and identify candidate genes for agronomic traits in crops of the Amaranthaceae family. Her work bridges bioinformatics with plant breeding and conservation genetics. The recent publications highlight a strong trend in plant genome analysis , particularly focusing on beet and spinach. Key themes include genome assembly, structural variation, domestication history, and gene discovery using machine learning. Several studies employ k-mer-based phylogenetics and haplotype analysis to explore evolutionary dynamics and flowering time regulation. Additional work extends into microbial genomics and metatranscriptomics, particularly in livestock and industrial yeast systems. Juliane Dohm has supervised numerous Master’s and PhD theses in bioinformatics and genomics, mentoring students in areas such as quinoa subgenome separation, beet structural variation, and spinach genomics. She is involved in multiple externally funded research projects, including FWF- and EU-supported initiatives on beet genomics and crop wild relative conservation. She also contributes to the scientific community through conference organization and presentations at major bioinformatics events. She leads research within the Institute of Computational Biology , collaborating closely with Heinz Himmelbauer and contributing to the development of genomic resources for key crops. Her lab utilizes advanced sequencing technologies and computational pipelines to generate high-quality genome assemblies and functional annotations.